Atlas Trials

Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma

Clinical trial NCT00930345 · TERMINATED

Trial details

NCT number
NCT00930345
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Metastatic Renal Cell Carcinoma
Start date
2008-12-01
Primary completion
2013-10-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.